In a non-obese rodent model of T2D exhibiting metabolic syndrome, we have further observed that SKA-31 dose-dependently increased total coronary flow to levels similar to that in control hearts, suggesting that endothelial KCa channel activity per se is not impaired in this model of T2D [5]. The gene discussed is CSN3; the disease is type 2 diabetes mellitus.